Clinical trial
A Phase 1 Study of Kappa and Mu Opioid Receptor Occupancy Associated With Repeated Dosing of LY24516302
NCT02218775 is registered in ClinicalTrials.gov with Andrew Krystal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of Kappa and Mu Opioid Receptor Occupancy Associated With Repeated Dosing of LY24516302
- Lead sponsor
- Andrew Krystal
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- October 31, 2014
- Completion date
- April 30, 2015
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.